Fidaxomicin Versus Vancomycin for Clostridioides Difficile Treatment
April 15th 2022Concomitant antibiotic (CA) use for infection treatment is a major risk factor for recurrent C difficile infection. One SHEA 2022 study examined whether fidaxomicin or vancomycin would be more beneficial for CA patients.
Read More
COVID-19 Risk Factors, Broken Down by Occupation
April 13th 2022An examination of COVID-19 infections by occupation found that most cases occurred in people who worked in management and healthcare, and COVID-19 death rates were highest among building/grounds cleaning and maintenance employees.
Read More
Discontinuing Contact Precautions for MRSA, VRE Did Not Affect HAI Rates, Study Finds
April 26th 2019The aggregated average HAI rates before and after discontinuing contact precautions were 0.14 and 0.15 MRSA HAI/1000 patient days, 0.06 and 0.04 VRE HAI/1000 patient days, and 0.04 and 0.03 MRSA LabID events/100 admissions.
Read More